Orexo AB (publ)
SSE:ORX.ST
Overview | Financials
Company Name | Orexo AB (publ) |
Symbol | ORX.ST |
Currency | SEK |
Price | 14.5 |
Market Cap | 498,329,867 |
Dividend Yield | 0% |
52-week-range | 8.44 - 20.1 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Nikolaj Sorensen |
Website | https://www.orexo.com |
An error occurred while fetching data.
About Orexo AB (publ)
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD